After-Hours Stock Movers 05/19: (SRPT) (DY) (CSC) Higher; (ETSY) (CISG) (NCLH) Lower (more..)

May 19, 2015 6:07 PM EDT

Sarepta Therapeutics (NASDAQ: SRPT) 37.4% HIGHER; announced that the Company held a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) regarding its lead product candidate, eteplirsen, for the treatment of Duchenne muscular dystrophy (DMD). Sarepta has agreed with the Agency to initiate a rolling NDA submission and will submit the non-clinical and CMC components of the NDA by the end of this week. As previously announced, Sarepta plans to submit the final component of the NDA by mid-year 2015.

Etsy (NASDAQ: ETSY) 17% LOWER; reported Q1 EPS of ($0.84), versus ($0.01) reported last year. Revenue for the quarter came in at $58.54 million, versus $40.54 million reported last year.

Dycom Industries (NYSE: DY) 14.8% HIGHER; reported Q3 EPS of $0.58, $0.21 better than the analyst estimate of $0.37. Revenue for the quarter came in at $492.4 million versus the consensus estimate of $468.2 million. Dycom Industries sees Q4 2015 EPS of $0.74-$0.82, versus the consensus of $0.58. Dycom Industries sees Q4 2015 revenue of $550-570 million, versus the consensus of $522.81 million.

CNinsure (NASDAQ: CISG) 8.5% LOWER; reported Q1 EPS of $0.07, $0.03 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $93.5 million versus the consensus estimate of $91.3 million.

Computer Sciences (NYSE: CSC) 4.4% HIGHER; announced that its Board of Directors has unanimously approved a plan to separate the company into two publicly traded, pure-play leaders: one to serve commercial and government clients globally and one to serve public sector clients in the U.S.

Norwegian Cruise Line (NASDAQ: NCLH) 4% LOWER; announced the launch of a secondary public offering of 20 million of its ordinary shares by certain funds affiliated with Apollo Global Management, LLC, Star NCLC Holdings Ltd. and certain funds affiliated with TPG Global, LLC pursuant to an automatic shelf registration statement on Form S-3 filed with the U.S. Securities and Exchange Commission. Norwegian will not sell any ordinary shares in the offering and will not receive any of the proceeds from the offering. The total number of Norwegian ordinary shares outstanding will not change as a result of the offering. Goldman, Sachs & Co. is acting as the sole underwriter for the offering

Cimarex Energy (NYSE: XEC) 3.7% LOWER; announced that it intends to commence a registered public offering of 6,000,000 shares of its common stock, subject to market conditions. Cimarex also expects to grant the underwriters an option to purchase up to 900,000 additional shares of its common stock. Net proceeds from the offering are expected to be used for general corporate purposes and to fund increased drilling and completion activity in the second half of 2015 and more significantly in 2016. J.P. Morgan and Barclays are acting as joint book-running managers for the offering.

Lending Club (NYSE: LC) 2.8% HIGHER; Morgan Stanley upgraded from Equalweight to Overweight

Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) 2.7% LOWER; Janssen Pharmaceuticals, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has entered into an exclusive worldwide license and collaboration arrangement with Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) to develop and commercialize one or more of Achillion's lead hepatitis C virus (HCV) assets which include ACH-3102, ACH-3422 and sovaprevir.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

JPMorgan, Morgan Stanley, Barclays, After-Hours Movers, S3